Author

I. Plo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

I. Antony-Debre· 2 shared J.-E. Martin· 2 shared A. Balduini· 1 shared A. Cumin· 1 shared A. Donada· 1 shared A. Hamblin· 1 shared A. J. Mead· 1 shared A. L. Chedeville· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

I. Antony-Debre

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis

H. Raslova, F. Basso-Valentina, A. Donada, V. T. Manchev, M. Lisetto, N. Balayn, J.-E. Martin, D. Muller, C. P. Marin Oyarzun, H. Duparc, B. Arkoun, A. Cumin, N. Droin, L. Faivre, I. Biunno, , R. Favier

This study identifies ANKRD26 as a regulator of type I cytokine receptor signaling in hematopoiesis, showing its role in progenitor proliferation and differentiation.

bioRxiv · Sep 1, 2022Cell Biology

Deciphering TP53 mutant Cancer Evolution with Single-Cell Multi-Omics

A. Rodriguez-Meira, R. Norfo, W. X. Wen, A. L. Chedeville, H. Rahman, J. OSullivan, G. Wang, E. Louka, W. Kretzschmar, A. Paterson, C. Brierley, J.-E. Martin, C. Demeule, M. Bashton, N. Sousos, , A. J. Mead

The paper uses single-cell multi-omic analysis to study TP53-mutant cancer evolution in leukaemia, identifying a role for chronic inflammation in promoting TP53 mutant clones.

bioRxiv · Mar 28, 2022 · PreprintCancer Biology